Category: Pharma Industry

PhRMA Petitions Supreme Court to Overturn Arkansas’ 340B Contract Pharmacy Access Law

August 1, 2024 William Newton, Associate Editor/Senior Writer Views

PhRMA petitioned the U.S. Supreme Court to take a case on the constitutionality of Arkansas' 340B contract pharmacy access law.

A powerful drug industry trade group has asked the U.S. Supreme Court to overturn a federal appeals court’s decision to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two Hospitals Sue HRSA to Block ‘Unlawfully Authorized’ Drugmaker 340B Program Audits

July 26, 2024 William Newton, Associate Editor/Senior Writer Views

Oregon Health & Science University Hospital is one of two 340B hospitals to sue HRSA over approving a drugmaker audit. (Photo by M.O. Stevens)

Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck, Wisconsin Health System Join 340B Working Table; 300+ Firms Lobbied on 340B in Q2

July 25, 2024 Shannon Young, Associate Editor/Senior Writer Views

Merck and Marshfield Clinic Health System have joined the growing list of organizations in the 340B Working Table.

New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

July 23, 2024 William Newton, Associate Editor/Senior Writer Views

Adventist Health System/West alleged in a lawsuit that four major drugmakers defrauded the federal government by overcharging for 340B drugs.

A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

First Drugmaker Sues Missouri Over its 340B Contract Pharmacy Access Law

July 23, 2024 William Newton, Associate Editor/Senior Writer Views

AbbVie asked a federal district court to declare unconstitutional Missouri's 340B contract pharmacy access law.

Pharmaceutical giant AbbVie yesterday became the first drugmaker to file suit against Missouri’s new law prohibiting 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck, Jazz Pharmaceuticals Exempt States from 340B Contract Pharmacy Restrictions — Including First for Missouri

July 23, 2024 William Newton, Associate Editor/Senior Writer Views

Merck became the first drugmaker to announce it would loosen its 340B contract pharmacy restrictions in Missouri in response to a new state law.

Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Massachusetts 340B Measures Addressing PBM Discrimination and Medicaid Drug Coverage Fall Short in Senate, Sponsor Plans to Refile Bill Next Session

July 19, 2024 Shannon Young, Associate Editor/Senior Writer Views

A contract pharmacy access bill could still pass in Massachusetts despite the end of the formal legislative session.

The Massachusetts Senate on Thursday failed to adopt legislation that would have prohibited pharmacy benefit managers (PBMs) from imposing discriminatory [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Maryland

July 18, 2024 William Newton, Associate Editor/Senior Writer & Shannon Young, Associate Editor/Senior Writer Views

Federal district courts in Maryland and Mississippi saw various legal actions related to state 340B contract pharmacy access laws in the past week.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

SK Life Science Posts Refund Notice; Dr. Reddy’s and Pfizer Issue NDC Changes

July 18, 2024 Bella Czajkowski, National Correspondent Views

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.

SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Proposes Rule to Exclude 340B Claims from Inflation Rebates; Reflects ‘Stronger Understanding’ of 340B than IRA Negotiation Guidance, Says Attorney

July 16, 2024 William Newton, Associate Editor/Senior Writer Views

CMS recently proposed a rule to fulfill its statutory obligation to exclude 340B claims from Medicare inflationary rebates.

The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

PhRMA Petitions Supreme Court to Overturn Arkansas’ 340B Contract Pharmacy Access Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Two Hospitals Sue HRSA to Block ‘Unlawfully Authorized’ Drugmaker 340B Program Audits

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Merck, Wisconsin Health System Join 340B Working Table; 300+ Firms Lobbied on 340B in Q2

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

Please Login or Become a Paid Subscriber to View this Content

If you are already a

First Drugmaker Sues Missouri Over its 340B Contract Pharmacy Access Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Merck, Jazz Pharmaceuticals Exempt States from 340B Contract Pharmacy Restrictions — Including First for Missouri

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Massachusetts 340B Measures Addressing PBM Discrimination and Medicaid Drug Coverage Fall Short in Senate, Sponsor Plans to Refile Bill Next Session

Please Login or Become a Paid Subscriber to View this Content

If you are already a

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Maryland

Please Login or Become a Paid Subscriber to View this Content

If you are already a

SK Life Science Posts Refund Notice; Dr. Reddy’s and Pfizer Issue NDC Changes

Please Login or Become a Paid Subscriber to View this Content

If you are already a

CMS Proposes Rule to Exclude 340B Claims from Inflation Rebates; Reflects ‘Stronger Understanding’ of 340B than IRA Negotiation Guidance, Says Attorney

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live